Editors:
- Diskussion der Vor- und Nachteile der Hormonerstatztherapie
- Schwerpunkt der Diskussion ist Bruskrebsrisiko
- Contains an advanced level discussion on the appropriateness of hormone replacement therapy (HRT)
- Addresses all aspects and risks associated with HRT
- Provides detailed review of controversy
- Includes supplementary material: sn.pub/extras
Part of the book series: Ernst Schering Foundation Symposium Proceedings (SCHERING FOUND, volume 13)
Part of the book sub series: Schering Foundation Symposium Proceedings Supplements (3368)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (15 papers)
-
Front Matter
-
The Presentations
-
Front Matter
-
-
The General Discussion
-
Front Matter
-
-
Conclusions of the Kloster Andechs Workshop
-
Front Matter
-
-
Back Matter
About this book
Die Vor- und Nachteile der Hormonersatztherapie (HRT) werden von einer Expertengruppe hinsichtlich der epidemiologischen Beweislage diskutiert. Obwohl alle positiven und negativen Aspekte der HRT behandelt werden, liegt der Schwerpunkt der Diskussionen bei der Frage des Brustkrebsrisikos. Unter anderem wird gezeigt, dass die aus epidemiologischen Studien abgeleiteten Ergebnisse sich nicht mit den Wachstumseigenschaften dieser Tumoren decken so dass weiterführende Bevölkerungsuntersuchungen unter Einbeziehungen pathobiologischen Sachverstands notwendig erscheinen.
This volume contains an advanced level discussion on the appropriateness of hormone replacement therapy (HRT) in modern postmenopausal women on the basis of the current evidence provided by recent epidemiological studies. It addresses all aspects of benefits and risks associated with HRT, including issues concerning psychology, the cardiovascular system, bone structure, and carcinogenesis. It focuses, however, on cancer risk and on risk of breast cancer in particular. In doing so, it provides a detailed discussion of the pathobiological features of breast cancer, concluding that the evidence provided by epidemiological studies is in conflict with the biological growth features of breast cancer. It advocates further epidemiological studies which incorporate pathobiological assessments.
Editors and Affiliations
-
EPES Epidemiologie, Pharmakoepidemiologie, und Systemforschung GmbH, Berlin, Germany
M. A. Lewis
-
Charité — Institut für Pathologie, Berlin, Germany
M. Dietel
-
Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München, Munich, Germany
P. C. Scriba
-
Berlin, Germany
W. K. Raff
Bibliographic Information
Book Title: Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy
Book Subtitle: Diskussionen zur Postmenopausalen Gesundheit - Discussions on Post-Menopausal Health
Editors: M. A. Lewis, M. Dietel, P. C. Scriba, W. K. Raff
Series Title: Ernst Schering Foundation Symposium Proceedings
DOI: https://doi.org/10.1007/978-3-540-37861-7
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2006
Hardcover ISBN: 978-3-540-32341-9Published: 25 July 2006
Softcover ISBN: 978-3-642-42162-4Published: 26 November 2014
eBook ISBN: 978-3-540-37861-7Published: 24 May 2007
Series ISSN: 0947-6075
Edition Number: 1
Number of Pages: XV, 179
Topics: Gynecology, Epidemiology, Oncology, Pathology